The small molecule XX-650-23 blocks the interaction between CREB and its co-activator CBP (CREB-binding protein) and then abrogates CREB-responsive gene expression, leading to AML cells apoptosis and cell-cycle arrest [145, 146]. Here, CREBBP is linked to acute myeloid leukemia.